Located in Seattle, the Solid Tumor Translational Research (STTR) group is comprised of investigators from four leading Northwest institutions - Fred Hutchinson Cancer Research Center, UW Medicine, Seattle Cancer Care Alliance and Seattle Children’s Hospital.
Our multidisciplinary, multi-institutional team uses state-of-the-art technology and scientific innovation to turn laboratory findings, population studies and clinical insights into clinical practice. The goals of the program are to enhance the understanding of cancer biology and therapeutic responses and to identify personalized treatments that improve patient outcomes.
We have initially established programs for tumors of the brain, breast, colon, head and neck, lung, ovaries, pancreas and prostate. Using genomics, bioinformatics, mathematical modeling and other techniques, scientists and clinicians compare patient information with laboratory findings to tailor treatment options.
The STTR fosters and promotes intellectual participation and collaboration with lectures, retreats, working groups, protocol development, biospecimen collection and utilization, joint publications and grants.
We believe there are many promising cancer therapies on the horizon. Combining our expertise will enable the design and delivery of the new therapies more efficiently and quickly to patients.